Terms: = Leukemia AND CREBBP, CBP, 1387, ENSG00000005339, RSTS, RTS AND Diagnosis
38 results:
1. Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303.
Russler-Germain DA; Krysiak K; Ramirez C; Mosior M; Watkins MP; Gomez F; Skidmore ZL; Trani L; Gao F; Geyer S; Cashen AF; Mehta-Shah N; Kahl BS; Bartlett NL; Alderuccio JP; Lossos IS; Ondrejka SL; Hsi ED; Martin P; Leonard JP; Griffith M; Griffith OL; Fehniger TA
Blood Adv; 2023 Sep; 7(18):5524-5539. PubMed ID: 37493986
[TBL] [Abstract] [Full Text] [Related]
2. De novo monocytic-M5b AML with t(8;16) (p11.2; p13.3) KAT6A/crebbp fusion and FLT3-TKD mutation complicated by chemotherapy-induced Takotsubo cardiomyopathy.
Ananthaneni A; Benzar T; Hafiz N; Akabane H
BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36977512
[TBL] [Abstract] [Full Text] [Related]
3. Advances in the Treatment of Hairy Cell leukemia Variant.
Tran J; Gaulin C; Tallman MS
Curr Treat Options Oncol; 2022 Jan; 23(1):99-116. PubMed ID: 35178674
[TBL] [Abstract] [Full Text] [Related]
4. Glucocorticoid receptor gene mutations confer glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia.
Tamai M; Kasai S; Akahane K; Thu TN; Kagami K; Komatsu C; Abe M; Watanabe A; Goi K; Miyake K; Inaba T; Takita J; Goto H; Minegishi M; Iwamoto S; Sugita K; Inukai T
J Steroid Biochem Mol Biol; 2022 Apr; 218():106068. PubMed ID: 35124168
[TBL] [Abstract] [Full Text] [Related]
5. Targeted massively parallel sequencing of mature lymphoid neoplasms: assessment of empirical application and diagnostic utility in routine clinical practice.
Davis AR; Stone SL; Oran AR; Sussman RT; Bhattacharyya S; Morrissette JJD; Bagg A
Mod Pathol; 2021 May; 34(5):904-921. PubMed ID: 33311649
[TBL] [Abstract] [Full Text] [Related]
6. Multiclonal complexity of pediatric acute lymphoblastic leukemia and the prognostic relevance of subclonal mutations.
Antić Ž; Yu J; Van Reijmersdal SV; Van Dijk A; Dekker L; Segerink WH; Sonneveld E; Fiocco M; Pieters R; Hoogerbrugge PM; Van Leeuwen FN; Van Kessel AG; Waanders E; Kuiper RP
Haematologica; 2021 Dec; 106(12):3046-3055. PubMed ID: 33147938
[TBL] [Abstract] [Full Text] [Related]
7. Mutational landscape and patterns of clonal evolution in relapsed pediatric acute lymphoblastic leukemia.
Waanders E; Gu Z; Dobson SM; Antić Ž; Crawford JC; Ma X; Edmonson MN; Payne-Turner D; van de Vorst M; Jongmans MCJ; McGuire I; Zhou X; Wang J; Shi L; Pounds S; Pei D; Cheng C; Song G; Fan Y; Shao Y; Rusch M; McCastlain K; Yu J; van Boxtel R; Blokzijl F; Iacobucci I; Roberts KG; Wen J; Wu G; Ma J; Easton J; Neale G; Olsen SR; Nichols KE; Pui CH; Zhang J; Evans WE; Relling MV; Yang JJ; Thomas PG; Dick JE; Kuiper RP; Mullighan CG
Blood Cancer Discov; 2020 Jul; 1(1):96-111. PubMed ID: 32793890
[TBL] [Abstract] [Full Text] [Related]
8. Expanding the phenotype associated to KMT2A variants: overlapping clinical signs between Wiedemann-Steiner and Rubinstein-Taybi syndromes.
Di Fede E; Massa V; Augello B; Squeo G; Scarano E; Perri AM; Fischetto R; Causio FA; Zampino G; Piccione M; Curridori E; Mazza T; Castellana S; Larizza L; Ghelma F; Colombo EA; Gandini MC; Castori M; Merla G; Milani D; Gervasini C
Eur J Hum Genet; 2021 Jan; 29(1):88-98. PubMed ID: 32641752
[TBL] [Abstract] [Full Text] [Related]
9. t(11;16)(q23;p13)/KMT2A-crebbp in hematologic malignancies: presumptive evidence of myelodysplasia or therapy-related neoplasm?
Xie W; Tang G; Wang E; Kim Y; Cloe A; Shen Q; Zhou Y; Garcia-Manero G; Loghavi S; Hu AY; Wang S; Bueso-Ramos CE; Kantarjian HM; Medeiros LJ; Hu S
Ann Hematol; 2020 Mar; 99(3):487-500. PubMed ID: 32006151
[TBL] [Abstract] [Full Text] [Related]
10. Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia.
Li B; Brady SW; Ma X; Shen S; Zhang Y; Li Y; Szlachta K; Dong L; Liu Y; Yang F; Wang N; Flasch DA; Myers MA; Mulder HL; Ding L; Liu Y; Tian L; Hagiwara K; Xu K; Zhou X; Sioson E; Wang T; Yang L; Zhao J; Zhang H; Shao Y; Sun H; Sun L; Cai J; Sun HY; Lin TN; Du L; Li H; Rusch M; Edmonson MN; Easton J; Zhu X; Zhang J; Cheng C; Raphael BJ; Tang J; Downing JR; Alexandrov LB; Zhou BS; Pui CH; Yang JJ; Zhang J
Blood; 2020 Jan; 135(1):41-55. PubMed ID: 31697823
[TBL] [Abstract] [Full Text] [Related]
11. Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second-generation tyrosine kinase inhibitors.
Nteliopoulos G; Bazeos A; Claudiani S; Gerrard G; Curry E; Szydlo R; Alikian M; Foong HE; Nikolakopoulou Z; Loaiza S; Khorashad JS; Milojkovic D; Perrotti D; Gale RP; Foroni L; Apperley JF
Haematologica; 2019 Dec; 104(12):2400-2409. PubMed ID: 31073075
[TBL] [Abstract] [Full Text] [Related]
12. Mutational spectrum and associations with clinical features in patients with acute myeloid leukaemia based on next‑generation sequencing.
Li Y; Lv X; Ge X; Yuan D; Ding M; Zhen C; Zhao W; Liu X; Wang X; Xu H; Li Y; Wang X
Mol Med Rep; 2019 May; 19(5):4147-4158. PubMed ID: 30942411
[TBL] [Abstract] [Full Text] [Related]
13. Descriptive analysis of genetic aberrations and cell of origin in Richter transformation.
Chitalia A; Swoboda DM; McCutcheon JN; Ozdemirli M; Khan N; Cheson BD
Leuk Lymphoma; 2019 Apr; 60(4):971-979. PubMed ID: 30632835
[TBL] [Abstract] [Full Text] [Related]
14. The incidence and distribution characteristics of MLL rearrangements in Chinese acute myeloid leukemia patients by multiplex nested RT-PCR.
Yang H; Cao T; Gao L; Wang L; Zhu C; Xu Y; Jing Y; Zhu H; Lv N; Yu L
Technol Health Care; 2017 Jul; 25(S1):259. PubMed ID: 28582914
[TBL] [Abstract] [Full Text] [Related]
15. Low crebbp expression is associated with adverse long-term outcomes in paediatric acute lymphoblastic leukaemia.
Gao C; Zhang RD; Liu SG; Zhao XX; Cui L; Yue ZX; Li WJ; Chen ZP; Li ZG; Rao Q; Wang M; Zheng HY; Wang JX
Eur J Haematol; 2017 Aug; 99(2):150-159. PubMed ID: 28452416
[TBL] [Abstract] [Full Text] [Related]
16. Mutational profiling of acute lymphoblastic leukemia with testicular relapse.
Ding LW; Sun QY; Mayakonda A; Tan KT; Chien W; Lin DC; Jiang YY; Xu L; Garg M; Lao ZT; Lill M; Yang H; Yeoh AE; Koeffler HP
J Hematol Oncol; 2017 Mar; 10(1):65. PubMed ID: 28253933
[TBL] [Abstract] [Full Text] [Related]
17. Mutational Landscape of Pediatric Acute Lymphoblastic leukemia.
Ding LW; Sun QY; Tan KT; Chien W; Mayakonda A; Yeoh AEJ; Kawamata N; Nagata Y; Xiao JF; Loh XY; Lin DC; Garg M; Jiang YY; Xu L; Lim SL; Liu LZ; Madan V; Sanada M; Fernández LT; Hema Preethi SS; Lill M; Kantarjian HM; Kornblau SM; Miyano S; Liang DC; Ogawa S; Shih LY; Yang H; Koeffler HP
Cancer Res; 2017 Jan; 77(2):390-400. PubMed ID: 27872090
[TBL] [Abstract] [Full Text] [Related]
18. Mutations in epigenetic regulators are involved in acute lymphoblastic leukemia relapse following allogeneic hematopoietic stem cell transplantation.
Xiao H; Wang LM; Luo Y; Lai X; Li C; Shi J; Tan Y; Fu S; Wang Y; Zhu N; He J; Zheng W; Yu X; Cai Z; Huang H
Oncotarget; 2016 Jan; 7(3):2696-708. PubMed ID: 26527318
[TBL] [Abstract] [Full Text] [Related]
19. FOXO3a and Posttranslational Modifications Mediate Glucocorticoid Sensitivity in B-ALL.
Consolaro F; Ghaem-Maghami S; Bortolozzi R; Zona S; Khongkow M; Basso G; Viola G; Lam EW
Mol Cancer Res; 2015 Dec; 13(12):1578-90. PubMed ID: 26376801
[TBL] [Abstract] [Full Text] [Related]
20. KRAS and crebbp mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia.
Malinowska-Ozdowy K; Frech C; Schönegger A; Eckert C; Cazzaniga G; Stanulla M; zur Stadt U; Mecklenbräuker A; Schuster M; Kneidinger D; von Stackelberg A; Locatelli F; Schrappe M; Horstmann MA; Attarbaschi A; Bock C; Mann G; Haas OA; Panzer-Grümayer R
Leukemia; 2015 Aug; 29(8):1656-67. PubMed ID: 25917266
[TBL] [Abstract] [Full Text] [Related]
[Next]
